Abstract
Objective:
To evaluate whether early treatment with inhaled nitric oxide (iNO) will prevent newborns with moderate respiratory failure from developing severe hypoxemic respiratory failure (oxygenation index (OI)⩾40).
Study Design:
A total of 56 newborns with moderate respiratory failure (OI between 10 and 30) were randomized before 48 h after birth to early treatment with 20 p.p.m. of iNO (Early iNO group, n=28) or conventional mechanical ventilation with FiO2 1.0 (Control group, n=28). Infants received iNO and/or high-frequency oscillatory ventilation (HFOV) if they developed an OI>40.
Result:
7 of 28 early iNO patients (25%) compared to 17 of 28 control patients (61%) developed an OI>40 (P<0.05). In the Early iNO group mean OI significantly decreased from 22 (baseline) to 19 at 4 h (P<0.05) and remained lower over time: 19 (12 h), 18 (24 h) and 16 at 48 h. In contrast, OI increased in the Control group and remained significantly higher than the Early iNO group during the first 48 h of study: 22 (baseline), 29, 35, 32 and 23 at 4, 12, 24 and 48 h, respectively (P<0.01). Of 17, 6 control patients who developed an OI>40 were successfully treated with iNO. Nine of the remaining eleven control patients and six of seven Early iNO patients who had an OI>40 despite use of iNO responded with the addition of HFOV. One patient of the Early iNO group and two of the Control group died. Median (range) duration of oxygen therapy was significantly shorter in the Early iNO group: 11.5 (5 to 90) days compared to 18 (6 to 142) days of the Control group (P<0.03).
Conclusion:
Early use of iNO in newborns with moderate respiratory failure improves oxygenation and decreases the probability of developing severe hypoxemic respiratory failure.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Morin FC, Stenmark KR . Persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med 1995; 151: 2010–2032.
Fox WW, Duara S . Persistent pulmonary hypertension in the neonate: diagnosis and management. J Pediatr 1983; 103: 505–514.
Durmowicz AG, Stenmark KR . Mechanisms of structural remodeling in chronic hypoxic pulmonary hypertension. Pediatr Rev 1999; 20: 91–102.
Aschner JL, Fike CD . New developments in the pathogenesis and management of neonatal pulmonary hypertension In: Bancalari E, Polin R (eds). The Newborn Lung: Neonatology Questions and Controversies. Sauders Elsevier Inc.: Philadelphia, PA: 2008: p 241–299.
Walsh-Sukys MC, Tyson JE, Wright LL, Bauer CR, Korones SB, Stevenson DK et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variations and outcomes. Pediatrics 2000; 105: 14–20.
González A, Fabres J, Cifuentes J, Kattan J, Estay A, Tapia JL et al. Tratamiento de la hipertensión Pulmonar persistente severa neonatal con oxido nitrico inhalatorio. Libro de Resúmenes XI Congreso Latinoamericano de Pediatría 1998; 175–176.
Frostell C, Fratacci M, Wain JC, Jones R, Zapol WN . Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991; 83: 2038–2047.
Berger J, Gibson R, Redding G, Standaert TA, Clarke NR, Truog WE . Effect of inhaled nitric oxide during group B streptococcal sepsis in piglets. Am Rev Respir Dis 1993; 147: 1080–1086.
Kinsella J, Neish S, Shaffer E, Abman S . Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 819–820.
Roberts J, Polaner D, Lang P, Zapol WM . Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 818–820.
The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term infants with hypoxic respiratory failure. N Engl J Med 1997; 336: 597–604.
Roberts JD, Fineman JR, Morin FC, Shaul PW, Rimar S, Schreiber MD et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med 1997; 336: 605–610.
Clark R, Kueser T, Walker MW, Southgate WM, Huckaby JL, Perez JA et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl J Med 2000; 342: 469–474.
Kinsella J, Parker TA, Galan H, Sheridan BC, Halbower AC, Abman SH et al. Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatr Res 1997; 41: 457–463.
Roberts JD, Chiche JD, Weimann J, Steudel W, Zapol WM, Bloch KD . Nitric oxide inhalation decreases pulmonary artery remodeling in the injured lungs of rat pups. Circ Res 2000; 87: 140–145.
Davidson D, Barefield ES, Kattwinkel J, Dudell G, Darmask M, Straube R et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. Pediatrics 1998; 101: 325–334.
The Franco-Belgium Collaborative Group. Early compared with delayed inhaled nitric oxide in moderately hypoxemic neonates with respiratory failure: a randomized controlled trial. Lancet 1999; 354: 1066–1071.
Sadiq HF, Mantych G, Benawra RS, Devaskar UP, Hocker JR . Inhaled nitric oxide in the treatment of moderate persistent pulmonary hypertension of the newborn: a randomized controlled, multicenter trial. J Perinatol 2003; 23: 98–103.
Konduri GG, Solimano A, Sokol GM, Singer J, Ehrenkranz RA, Singhal N et al. A randomized trial of early versus standard inhaled nitric oxide therapy in term and near term newborn infants with hypoxic respiratory failure. Pediatrics 2004; 113: 559–564.
Konduri GG . New approaches for persistent pulmonary hypertension of newborn. Clin Perinatol 2004; 31: 591–611.
Schreiber M, Gin-Mestan K, Marks J, Huo D, Lee G, Srisuparp P . Inhaled nitric oxide in premature infants with respiratory distress syndrome. N Engl J Med 2003; 349: 2099–2107.
Kinsella JP, Cutter GR, Walsh WF, Gerstmann DR, Bose CL, Hart C et al. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med 2006; 355: 354–364.
Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD et al. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 2006; 355 (4): 343–353.
Barrignton K, Finer N . Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev 2009, Issue 1. Art no CD 000509. DOI 10.1002/14651858.CD000509.pub3.
Kinsella J, Truog W, Walsh W, Goldberg RN, Bancalari E, Mayock DE et al. Randomized, multicenter trial of inhaled nitric oxide and high frequency oscillatory ventilation in severe persistent pulmonary hypertension of the newborn. J Pediatr 1997; 131: 55–62.
Acknowledgements
We thank Alessandra Gederlini for her help with the statistical analyses. We also thank Margarita Bidegain and Ronald Goldberg for their critical review of the paper.
This study was funded in part by project DIPUC 96/01E, Pontificia Universidad Católica de Chile and AGA Chile SA.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
González, A., Fabres, J., D'Apremont, I. et al. Randomized controlled trial of early compared with delayed use of inhaled nitric oxide in newborns with a moderate respiratory failure and pulmonary hypertension. J Perinatol 30, 420–424 (2010). https://doi.org/10.1038/jp.2009.171
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2009.171
Keywords
This article is cited by
-
Novel scoring tool of hypoxemic respiratory failure and pulmonary hypertension for defining severity of persistent pulmonary hypertension of newborn
Journal of Perinatology (2023)
-
Worsened short-term clinical outcomes in a cohort of patients with iNO-unresponsive PPHN: a case for improving iNO responsiveness
Journal of Perinatology (2022)
-
Early use of combined exogenous surfactant and inhaled nitric oxide reduces treatment failure in persistent pulmonary hypertension of the newborn: a randomized controlled trial
Journal of Perinatology (2021)
-
Frequent mutation of hypoxia-related genes in persistent pulmonary hypertension of the newborn
Respiratory Research (2020)
-
Inhaled nitric oxide for neonates with persistent pulmonary hypertension of the newborn in the CINRGI study: time to treatment response
BMC Pediatrics (2019)